VentriJect
1 known investors
VentriJect develops the Seismofit System, a portable medical device that estimates VO2max (cardiorespiratory fitness) using seismocardiography and AI algorithms in under three minutes without requiring exercise. The device is used by healthcare providers, fitness professionals, and health clinics to assess cardiovascular fitness as part of preventative health screening.